miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2

miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1

(2014) Zhengyu Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Recent advances in osteosarcoma

(2014) Sander M Botter et al.   CURRENT OPINION IN PHARMACOLOGY

MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1

(2014) Hong Pei et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

MicroRNAs in cancer: biomarkers, functions and therapy

(2014) Josie Hayes et al.   TRENDS IN MOLECULAR MEDICINE

miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1

(2014) Enqi Li et al.   TUMOR BIOLOGY

miR-449a Regulates Proliferation and Chemosensitivity to Cisplatin by Targeting Cyclin D1 and BCL2 in SGC7901 Cells

(2013) Jianghong Hu et al.   DIGESTIVE DISEASES AND SCIENCES

MicroRNA-449a acts as a tumor suppressor in human bladder cancer through the regulation of pocket proteins

(2012) Hong Chen et al.   CANCER LETTERS

New targets and approaches in osteosarcoma

(2012) Jonathan Gill et al.   PHARMACOLOGY & THERAPEUTICS

Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing

(2009) Yao Zhao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

(2009) E J Noonan et al.   ONCOGENE

Bcl-2 and caspase-8 related anoikis resistance in human osteosarcoma MG-63 cells

(2008) D LIN et al.   CELL BIOLOGY INTERNATIONAL

Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma

(2007) Maria-Kyriaki A. Kaseta et al.   JOURNAL OF SURGICAL ONCOLOGY